Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
Single patient expanded access program to provide galinpepimut-S for eligible patients with AML or MDS who have no other treatment option.
Acute Myeloid Leukemia|Myelodysplastic Syndromes
BIOLOGICAL: Galinpepimut-S
Single patient expanded access program to provide galinpepimut-S for eligible patients with AML or MDS who have no other treatment option.